INKON Life Technology Co Ltd
INKON Life Technology Co., Ltd. focuses on building an ecological platform for chain of prevention / diagnosis / treatment / rehabilitation, providing medical services for tumors in China and internationally. It provides medical devices solution for radiotherapy, life support, image enhancement, and chronic disease treatment, as well as oncology medical services. The company was formerly known as… Read more
INKON Life Technology Co Ltd (300143) - Total Assets
Latest total assets as of June 2025: CN¥4.15 Billion CNY
Based on the latest financial reports, INKON Life Technology Co Ltd (300143) holds total assets worth CN¥4.15 Billion CNY as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
INKON Life Technology Co Ltd - Total Assets Trend (2007–2024)
This chart illustrates how INKON Life Technology Co Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
INKON Life Technology Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
INKON Life Technology Co Ltd's total assets of CN¥4.15 Billion consist of 50.2% current assets and 49.8% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 35.1% |
| Accounts Receivable | CN¥246.54 Million | 7.0% |
| Inventory | CN¥88.29 Million | 2.5% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥225.24 Million | 6.4% |
| Goodwill | CN¥693.29 Million | 19.6% |
Asset Composition Trend (2007–2024)
This chart illustrates how INKON Life Technology Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: INKON Life Technology Co Ltd's current assets represent 50.2% of total assets in 2024, an increase from 0.0% in 2007.
- Cash Position: Cash and equivalents constituted 35.1% of total assets in 2024, up from 1.8% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 25.0% of total assets, an increase from 4.0% in 2007.
- Asset Diversification: The largest asset category is goodwill at 19.6% of total assets.
INKON Life Technology Co Ltd Competitors by Total Assets
Key competitors of INKON Life Technology Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
INKON Life Technology Co Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - INKON Life Technology Co Ltd generates 0.44x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, INKON Life Technology Co Ltd generates $ 3.26 in net profit.
INKON Life Technology Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.38 | 1.14 | 4.77 |
| Quick Ratio | 2.26 | 1.04 | 4.65 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.02 Billion | CN¥ 114.09 Million | CN¥ 757.53 Million |
INKON Life Technology Co Ltd - Advanced Valuation Insights
This section examines the relationship between INKON Life Technology Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.37 |
| Latest Market Cap to Assets Ratio | 0.18 |
| Asset Growth Rate (YoY) | 47.3% |
| Total Assets | CN¥3.54 Billion |
| Market Capitalization | $637.77 Million USD |
Valuation Analysis
Below Book Valuation: The market values INKON Life Technology Co Ltd's assets below their book value (0.18 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: INKON Life Technology Co Ltd's assets grew by 47.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for INKON Life Technology Co Ltd (2007–2024)
The table below shows the annual total assets of INKON Life Technology Co Ltd from 2007 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥3.54 Billion | +47.35% |
| 2023-12-31 | CN¥2.40 Billion | +18.36% |
| 2022-12-31 | CN¥2.03 Billion | -18.00% |
| 2021-12-31 | CN¥2.47 Billion | -6.70% |
| 2020-12-31 | CN¥2.65 Billion | +35.44% |
| 2019-12-31 | CN¥1.96 Billion | -25.37% |
| 2018-12-31 | CN¥2.62 Billion | +0.43% |
| 2017-12-31 | CN¥2.61 Billion | +3.04% |
| 2016-12-31 | CN¥2.53 Billion | +37.05% |
| 2015-12-31 | CN¥1.85 Billion | +129.96% |
| 2014-12-31 | CN¥804.00 Million | -22.27% |
| 2013-12-31 | CN¥1.03 Billion | +3.44% |
| 2012-12-31 | CN¥999.85 Million | +20.43% |
| 2011-12-31 | CN¥830.26 Million | -2.47% |
| 2010-12-31 | CN¥851.32 Million | +278.97% |
| 2009-12-31 | CN¥224.64 Million | +36.75% |
| 2008-12-31 | CN¥164.27 Million | +17.14% |
| 2007-12-31 | CN¥140.23 Million | -- |